Home|Journals|Articles by Year Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Original Research

BTDMJB. 2011; 7(4): 130-135

Advanced glycation end–products and advanced oxidation protein products in patients with insulin dependent diabetes mellitus and first degree relatives

Alev Kural, Aysun Toker, Hatice Seval, Yasemin Döventaş, Filiz Basınoğlu, Macit Koldaş, Zuhal A. Sağlam.

Objective: There is no comprehensive information on the relationship of diabetic complications and the duration and severity of hyperglycemia. In this study, we aimed to determine oxidative stress markers in patients with insulin dependent diabetes mellitus and their first degree relatives.
Materials and Methods: 45 patients with Type I diabetes mellitus and 24 relatives of these patients were included in our study. Plasma advanced oxide protein products (AOPP), serum glucose, urea, creatinine, cholesterol, triglyceride, HDL-cholesterol, total protein, albumin, advanced glication end products (AGE) and HbA1c measurements were measured by appropriate methods.
Results: AOPP and AGE levels were found to be slightly elevated in diabetic patients with or without complications compared to the levels of first degree relatives however the difference was not statistically significant.
Conclusion: When we had compared the parameteres in two groups (insulin dependent diabetic patients and non diabetic parents or siblings), we found weak relation between glucose and AGE (r= 0.25, p

Key words: Type I Diabetes Mellitus, advanced glycation end products, advanced oxidation protein products, diabetes complications, first degree relatives

Article Language: Turkish English

Full-text options

Full-text Article

American Journal of Physiology, Biochemistry and Pharmacology


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.